NSE: SUPRIYA | BSE: 543434

Mid-range Performer

Download real time

687.65 -5.80 (-0.84%)

86.86% Gain from 52W Low

208.7K NSE+BSE Volume

NSE 11 Jul, 2025 3:31 PM (IST)

5,534.4

Market Cap

Above industry Median

1.8

Beta 1Year

Very High Volatility

Supriya Lifescience Ltd. share price target and research reports

Name: Latest research reports of Supriya Lifescience Ltd. authored by SBI Securities and published by - Trendlyne research reports.
Item: Supriya Lifescience Ltd.
Rating: 4
Author: SBI Securities

Latest analyst research reports with target prices and PDF download for SUPRIYA, BSE:543434 Supriya Lifescience Ltd.

Search Inside the pdf :

Supriya Lifescience Ltd.

22 Dec 2023

687.65

-0.84%

Pick of the Day (Short Term Delivery Call)

Accumulate: Supriya Lifescience Ltd.

SBI Securities

SLL has a niche product basket of 38 APIs with presence in therapeutic areas of Analgesics, Anti-histamine, vitamins, anti-asthmatics, anti-allergic and anti-malarial. The company has tied up with
Kalinga Institute of Technology for development of GelHeal and Quickblue Oral Kit.

Number of FII/FPI investors increased from 85 to 98 in Mar 2025 qtr.

Supriya Lifescience Ltd.

16 Dec 2021

687.65

-0.84%

Supriya Lifescience : IPO

IPO Note: Supriya Lifescience Ltd.

ICICI Securities Limited

Supriya has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between FY17 and FY21. SLL is among the largest exporters of Salbutamol Sulphate in India contributing to...

Number of FII/FPI investors increased from 85 to 98 in Mar 2025 qtr.

Supriya Lifescience Ltd.

16 Dec 2021

687.65

-0.84%

SUPRIYA LIFESCIENCES LTD.

IPO Note: Supriya Lifescience Ltd.

Hem Securities

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. As of October 31, 2021, company have niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic,...

Supriya Lifescience Ltd. is trading above its 200 day SMA of 681.3

Supriya Lifescience Ltd.

15 Dec 2021

687.65

-0.84%

Supriya Lifescience Ltd. IPO Note

IPO Note: Supriya Lifescience Ltd.

Ashika Research

Public issue of 2,55,47,445 Equity shares of Face value Total Public 2 each, (Comprising of fresh issue of 72,99,270 Equity Shares* (Rs. 200 cr.) and Offer for Sale of 1,82,48,175 Equity Shares* (Rs. 500 cr.) by Selling Shareholder)....

Supriya Lifescience Ltd. is trading below its 30 day SMA of 695.2

Supriya Lifescience Ltd.

15 Dec 2021

687.65

-0.84%